B.C. opioid rules were to reduce overdoses. But they cut cancer patients’ pain meds

Article content

Rule changes designed to reduce opioid overdose deaths in British Columbia in 2016 inadvertently harmed cancer and palliative-care patients by reducing their access to pain killers, a new study has found.

Article content

Article content

The study published this week in the Canadian Medical Association Journal describes the impact of a practice standard issued by the College of Physicians and Surgeons of B.C. that June, about two months after the province declared a public health emergency over opioid deaths.

Article content

Article content

The rule changes were designed to mitigate prescription drug misuse, including the over-prescribing of opioids among patients with chronic non-cancer related pain.

Article content

Article content

The rules weren’t meant for cancer and palliative-care patients, but lead author Dimitra Panagiotoglou said there was a “spillover” effect as doctors applied “aggressive tapering” of the painkillers.

Article content

“(With) the ongoing messages that physicians were getting at the time — opioids being bad — individuals decided to pull back on their prescribing, but there was this larger population-level effect in doing so,” she said.

Article content

“We focus on these two groups because far and wide, it’s considered completely acceptable to prescribe opioids for these groups and the concerns around opioids are very different,” she said of cancer and palliative-care patients.

Article content

There were already downward trends in opioid prescriptions for people with chronic non-cancer pain and those receiving palliative care, Panagiotoglou said, and the study shows that trend continued after the change.

Article content

But among cancer patients, there was a surprising “nose dive” in access to opioids right after the release of the new standard, said Panagiotoglou, who is an associate professor in the department of epidemiology, biostatistics and occupational health at McGill University.

Article content

Article content

The rules were legally enforceable, and physicians found non-compliant could be disciplined or fined under the Health Professions Act and College of Physicians and Surgeons of BC bylaws. The rules were revised in 2018 to address concerns that they were being misinterpreted.

Article content

The changes in 2016 set a recommended dose ceiling at 90 morphine milligram equivalents or less per day and used “strong language” around co-prescribing with benzodiazepines given the drug poisoning risk, Panagiotoglou said.

Article content

Among cancer patients, the study found opioid dispensations were 15 per cent lower per person than expected two years after the implementation of the 2016 rules. Over 30 days, that translates to 4.5 fewer days of supply, it says.

Article content

For people receiving palliative care, the per-person dosage was 6.1 per cent lower, translating to 1.8 fewer days’ supply, the study says, while for patients with chronic non-cancer pain — the target population of the rules — dispensations were 8.2 per cent lower.

Article content

“Over time, people were seeing a meaningful decline in their doses and in the days supplied,” Panagiotoglou said of the period between the implementation of the 2016 practice standard and its revision in 2018.